MedTrace Logo

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

NCT06358469 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 249

Last updated 2026-05-12

No results posted yet for this study

Summary

This study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?

Conditions

  • Vulvar Squamous Cell Carcinoma

Interventions

PROCEDURE

Surgery

Re-excision of vulvar cancer margin

OTHER

Active Surveillance

The investigator will follow the patient to watch for side effects and keep track of patient's health

Sponsors & Collaborators

  • Australia New Zealand Gynaecological Oncology Group

    collaborator OTHER

  • Canadian Cancer Trials Group

    lead NETWORK

Principal Investigators

  • Amy Jamieson · University of British Columbia, Vancouver, BC, Canada

  • Jessica McAlpine · BCCA-Vancouver Cancer Centre, Vancouver, BC Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-10
Primary Completion
2030-06-30
Completion
2031-11-30

Countries

  • Canada
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06358469 on ClinicalTrials.gov